baber/WOPTO huggingface dataset:
Patent AU-728840-B2 (AU)
Title: Marking of electronic documents in order to expose unauthorized publication
Inventor: HIPPELAINEN LASSI
IPC: G06F1/00
Filed: 1997-09-29
Granted: 2001-01-18
Abstract: A method of marking information to be produced in order to expose unauthorized copying. In the method, a user identifier is defined, a source file containing a substantial part of the information produced is created, and a different target file is created for each user on the basis of the source file and the user identifier. In the invention, several predefined modification rules are stored in a file in order to modify the information contained in the source file. Using a digital processor, a sequence of modification keys is generated on the basis of the user identifier, the locations of the source file to be modified are defined, and modifications are made in these locations, determining the nature and/or position of the modifications on the basis of the predefined modification rules and modification keys. From the content of the target file delivered to the user, it is possible to conclude a user-specific identifier and thereby the person responsible for the unauthorized copy.
Patent AU-681587-B2 (AU)
Title: Remotely actuated switch and protection circuit
Inventor: PRYOR DENNIS MALCOLM
IPC: H02H3/10
Filed: 1993-06-30
Granted: 1997-09-04
Abstract: PCT No. PCT/GB93/01371 Sec. 371 Date Dec. 21, 1994 Sec. 102(e) Date Dec. 21, 1994 PCT Filed Jun. 30, 1993 PCT Pub. No. WO94/01960 PCT Pub. Date Jun. 20, 1994A switching arrangement that can be connected in a communications channel comprising a pair of lines, between sets of terminal equipment, which comprises: (i) a pair of series switching circuits, each of which can be series connected in one of the lines and will open when subjected to an overcurrent in its associated line; and/or (ii) one or more shunt switching circuits connected between the lines, or between one or both the lines and earth, and will close when subjected to an overvoltage in its associated line; wherein the or each switching circuit can be remotely actuated by means of a test signal sent along the channel.
Patent AU-582772-B2 (AU)
Title: Phosphatidyl compounds, processes for their manufacture, and their use
Inventor: BASCHANG GERHARD
IPC: C07F9/09
Filed: 1985-07-25
Granted: 1989-04-13
Abstract: Described are phosphatidyl compounds of the formula I    <IMAGE>  (I) in which R1 represents C3-14-alkanoyl, benzoyl, the acyl radical of an  alpha -aminocarboxylic acid that is other than glycine, L-alanine and derivatives thereof having a substituted amino group, and of which the  alpha -amino group may be substituted by lower alkanoyl, lower alkoxycarbonyl or by benzyloxycarbonyl, or the acyl radical of a  beta -aminocarboxylic acid or an  alpha - or  beta -hydroxycarboxylic acid, T represents a group NH that is unsubstituted or is substituted by lower alkyl, or oxygen, Y represents dimethylene that is unsubstituted or is substituted by free, etherified or amidated carboxy, W represents hydrogen, and Z represents a 1,2-dihydroxyethyl, 2-hydroxyethyl or hydroxymethyl group, in which at least one of the hydroxy groups is esterified by an aliphatic C8-30-carboxylic acid or is etherified by an aliphatic C8-30-alcohol, or each of W and Z represents a hydroxymethyl group that is esterified by an aliphatic C8-30-carboxylic acid or is etherified by an aliphatic C8-30-alcohol, and their salts, and processes for their manufacture. The mentioned novel compounds, and structurally related compounds that are likewise described and that belong to the state of the art, are used for the propylaxis and treatment of viral infections.
Patent AU-624479-B2 (AU)
Title: Papermaking with a polymer latex
Inventor: WATANABE NAOTAKA
IPC: D21H17/43
Filed: 1990-02-26
Granted: 1992-06-11
Abstract: Disclosed are a papermaking method of preparing a paper having a reinforced strength wherein a polymer latex is added to a paper stock in an amount of from 2.5 to 30 % by weight. The polymer latex is prepared by neutralizing a seed polymer with an acid or a salt or by quaternizing it with a quaternizing agent. The surfaces of the emulsion grains are highly densely cationated. The seed polymer is formed by adding a monomer as represented by the following formula (I) or a mixture of the monomer (I) and copolymerizable ethylenic unsaturated monomer(s) (II) to a seed latex of a carboxyl-modified synthetic rubber latex or synthetic resin emulsion and polymerizing them: <CHEM>  R1 represents H or CH3;  R2 represents an alkylene group having from 2 to 5 carbon atoms; R3 and R4 each represent H or an alkyl group having from 1 to 5 carbon atoms;  A represents   - @-O- or   -@-NH-; and R1, R3 and R4 and so selected that the monomer is hardly soluble or insoluble in water.   The paper has a noticeably improved paper-strength.
Patent AU-633874-B2 (AU)
Title: Threshold ligand-receptor assay
IPC: G01N33/53
Filed: 1990-01-10
Granted: 1993-02-11
Abstract: This invention is directed to a ligand-receptor assay for determining the presence or amount of at least one target ligand, capable of competing with a ligand analogue conjugate for binding sites available on a ligand receptor, said ligand analogue conjugate comprising at least one ligand analogue coupled to a signal development element capable of emitting a detectable signal, in a fluid sample suspected of containing said target ligand, comprising the steps of:   a. contacting said fluid sample with ligand analogue conjugate and ligand receptor to form a reaction mixture, the relative amounts of ligand analogue conjugate and ligand receptor being such that in the absence of target ligand, and subsequent to substantially equilibrium binding, substantially all of the ligand analogue conjugate is bound to ligand receptor;   b. detecting the unbound ligand analogue conjugate; c. relating the detectable signal to the presence or amount of target ligand in the fluid sample. In one embodiment an optional means also is employed for removing receptor from the reaction mixture. In related claimed assay formats the analyte of interest may be either ligand receptor or ligand.
Patent AU-621464-B2 (AU)
Title: Process for continuously producing an anhydrous methyl acetate/methanol mixture
Inventor: ERPENBACH HEINZ
IPC: C07C67/08
Filed: 1990-03-15
Granted: 1992-03-12
Abstract: The anhydrous methyl acetate/methanol mixture is prepared by esterification of acetic acid with methanol in the presence of an acid esterification catalyst, in which the esterification is carried out in a distillation column in which n 20 to 50 distillation trays and in which
 a) the acetic acid is fed in together with a catalyst to a distillation tray which is at a distance of 0.5 n to 0.8 n, relative to the still pot,
 b) 50 to 80% by weight of the entire methanol is fed into the still pot and the remaining methanol to a distillation tray which is 2 to 10 trays above the tray at which acetic acid is fed in,
 c) methanol and acetic acid are fed into the distillation column at a molar ratio of (1.5 to 3) : 1,
 d) the reflux ratio is set to (0.75 to 1.5) : 1,
 e) the anhydrous methyl acetate/methanol mixture is removed at the top of the column and
 f) a bottom product comprising water/methanol/acetic acid is discharged together with the catalyst from the still pot.
Patent AU-734801-B2 (AU)
Title: Use of nerve growth factor for the storage, culture or treatment of cornea
Inventor: LAMBIASE ALESSANDRO
IPC: C12N5/02
Filed: 1997-11-21
Granted: 2001-06-21
Abstract: The nerve growth factor (NGF) is used for the storage of corneas in culture, for the production and the storage in vitro of single cell populations of the corneal morphological and functional unit (i.e. epithelium, stroma/keratocytes and endothelium) and of the conjunctival epithelium, and for the production and the storage of corneal and conjunctival tissues, in particular for transplantation purposes. The NGF is also proposed for use in the therapy and/or the prophylaxis of diseases of the corneal surface, wherein a lack of integrity of the corneal and conjunctival morphological and functional unit occurs, in particular for pathologies having a dystrophic or neurodystrophic basis, both congenital and acquired.
Patent AU-525051-B2 (AU)
Title: Preservation of urine
Inventor: MEHL JACK JUDSON
IPC: A61B10/00
Filed: 1979-10-16
Granted: 1982-10-14
Abstract: A liquid urine preservative is comprised of boric acid and an alkali metal formate which are dissolved in a bacteriostatic liquid, such as water or glycerine. The preservative may be included in an evacuated container for a urine sample to facilitate taking of correct sample amounts.
Patent AU-537002-B2 (AU)
Title: Preparation of emulsions
Inventor: MORAN DAVID PATRICK JOSEPH
IPC: A23D7/005
Filed: 1979-11-15
Granted: 1984-05-31
Abstract: This invention provides emulsions comprising a continuous fatty phase and a dispersed liquid aqueous phase and dispersed gelled aqueous ingredients, e.g. prepared by blending a gelling agent containing low fat spread in line with one free from gelling agents.
Patent AU-658337-B2 (AU)
Title: Benzimidazole derivatives, process for their preparation and application
Inventor: WHITTAKER MARK
IPC: A61K31/535
Filed: 1994-01-07
Granted: 1995-04-06
Abstract: Compounds of general formula I;   <IMAGE> I  wherein: A1 is =N-, =CH- or =CR1-; A2 is =N-, =CH- or =CR2-; provided that, when one of A1 and A2 is a nitrogen atom, the other of A1 and A2 is other than a nitrogen atom; wherein the other variables are as defined in the specification and their pharmaceutically and veterinarily acceptable acid addition salts and hydrates are antagonists of platelet activating factor (PAF) and as such are useful in the treatment or amelioration of various diseases or disorders mediated by PAF.
Patent AU-638245-B2 (AU)
Title: Preparation of liposome and lipid complex compositions
IPC: A61K31/135
Filed: 1990-03-28
Granted: 1993-06-24
Abstract: Liposome and lipidic particle formulations of compounds are prepared by dissolving in a solution of liposome-forming lipids in an aprotic solvent such as DMSO, optionally containing a lipid-solubilizing amount of a lower alkanol, and injecting the resulting solution into an aqueous solution. The resulting liposome or lipidic particle suspension may then be dialyzed or otherwise concentrated. This method is particularly useful for compounds which are poorly-soluble in aqueous solution, but is generally useful for any compound or combination of compounds which can be dissolved in the aprotic solvent or aprotic solvent/lower alkanol mixture.
Patent AU-671511-B2 (AU)
Title: Location updating in a cellular radio system
Inventor: LAATU JUHO
IPC: H04W60/04
Filed: 1993-11-30
Granted: 1996-08-29
Abstract: The invention relates to a cellular radio network and a method for performing location updating in a cellular radio system. The cellular radio network does not employ fixed location areas, as prior cellular radio networks do, but it employs a location area configuration which is subscriber station specific and dynamically adaptive. In connection with each location updating, it is therefore possible to select an optimal location area for the subscriber station at that particular moment, the selected location area being preferably of an arbitrary size and form. It is thus possible to define the location area subscriber station specifically in such a manner that, on one hand, it is sufficiently large so that the subscriber station does not have to perform location updating frequently but, on the other hand, sufficiently small so that the paging of the subscriber station does not load the cellular radio network too much. The network and method also allow the use of completely subscriber station specific location areas.
Patent AU-703179-B2 (AU)
Title: Recombinant canine gastric lipase and pharmaceutical compositions
Inventor: BLANCHARD CLAIRE
IPC: A61K38/00
Filed: 1993-12-16
Granted: 1999-03-18
Abstract: The present invention relates to dog gastric lipase as obtained by genetic engineering as well as to the nucleotide sequence encoding this recombinant DGL. It also relates to the use of this recombinant DGL for the production of pharmaceutical compositions intended especially for the treatment of pathologies linked to the insufficiency, or even the absence, of secretion of lipases in the body of an individual.
Patent AU-764610-B2 (AU)
Title: Method and signal processor for intensification of speech signal components in a hearing aid
Inventor: PALUDAN-MULLER CARSTEN
IPC: H04R25/00
Filed: 1999-10-07
Granted: 2003-08-28
Abstract: In a hearing aid signal processor with AGC in at least three processing channels (a, B, C) for different frequency bands and with noise squelching capability to affect the gain control in a t least a lowest frequency band (A) and one intermediate frequency band (B) speech signals components in the intermediate frequency band of an input signal including background noise are intensified by estimation of the content of speech signal components in at least the highest frequency band (C) and modification of the gain adjustment cause by noise squelching in the intermediate frequency band (B) to reduce the noise spending. <heading lvl="1">RELATED APPLICATION </heading> The present application is a continuation-in-part of PCT/DK99/00531, filed Oct. 7, 1999, now abandoned.
Patent AU-629966-B2 (AU)
Title: A microorganism for selective production of specific component of avermectin and a method for selective production thereof
Inventor: OMURA SATOSHI
IPC: C12R1/465
Filed: 1990-08-06
Granted: 1992-10-15
Abstract: 1. A microorganism of the genus Streptomyces which is capable of selectively producing a specific component of avermectin, said microorganism having one or more of the following properties:     specific accumulation of avermectin component "a", effective incorporation of isoleucine or the keto acid thereof (3-methyl-2-oxovaleric acid) into an avermectin molecule, and markedly suppressed incorporation of valine or the keto acid thereof (2-oxoisovaleric acid) into an avermectin molecule.   i
Patent AU-672890-B2 (AU)
Title: An additive for a polymeric composition
Inventor: JEFFS DAVID GEORGE
IPC: C09C3/10
Filed: 1994-05-11
Granted: 1996-10-17
Abstract: There is disclosed a coated particulate inorganic material, the coating on the particles of the inorganic material comprising a combination of a natural or synthetic polymeric material and a mould release agent. The mould release agent is a fatty acid having from 12 to 20 carbon atoms or a heavy metal or alkaline earth metal salt thereof. The polymeric material is present in the coating in an amount of from 1% to 10% by weight, based on the weight of dry inorganic material. The coated particulate inorganic material is useful as an improved low profile additive for polymeric compositions, and especially for thermosetting polymeric compositions which are specially adapted for forming shaped articles by sheet moulding or by bulk, or dough, moulding processes.
Patent AU-682351-B2 (AU)
Title: Skin cleansing formulations with terpene solvents and corn meal scrubber
Inventor: HERSH LESLIE J
IPC: C11D3/14
Filed: 1994-01-26
Granted: 1997-10-02
Abstract: PCT No. PCT/US94/00443 Sec. 371 Date Apr. 30, 1993 Sec. 102(e) Date Apr. 30, 1993 PCT Filed Jan. 26, 1994 PCT Pub. No. WO94/25001 PCT Pub. Date Nov. 10, 1994There is disclosed various terpene based cleansing formulations for skin. The cleaning formulations include the ingredients of water in which there is dispersed a terpene, nonionic surfactants, corn meal scrubber and preservatives including antimicrobial and antioxidant agents. In one aspect of the invention the skin cleansing formulations include orange terpenes as the solvent. The nonionic surfactants present in the formulation provide stabilization of the terpene/water mixture, do not soften or otherwise attack the corn meal, and provide detergency for suspending the lifted soil.
Patent AU-703340-B2 (AU)
Title: Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis
Inventor: WINCHELL HARRY S
IPC: A61K31/395
Filed: 1996-06-24
Granted: 1999-03-25
Abstract: The present invention refers to a method for inhibiting bacterial or fungal growth on a surface, including a human body surface, or in a solution comprising administering to said surface or solution a complexing agent having the formula <CHEM> wherein said radicals and integers are defined as in the description.
Patent AU-707093-B2 (AU)
Title: Compositions and methods for the synthesis of organophosphorus derivatives
Inventor: STEC WOJCIECH J
IPC: C07H19/20
Filed: 1996-08-29
Granted: 1999-07-01
Abstract: Methods for the stereospecific synthesis of chirally pure organophosphorus dinucleotide derivatives and nucleoside monomer synthons used in their synthesis are provided. These methods allow for conversion of nucleoside intermediates of unchosen sense of P-chirality to nucleoside monomer synthons of chosen sense of P-chirality. Also provided are novel nucleoside intermediates useful in such methods.
Patent AU-635376-B2 (AU)
Title: Mixture of polyvinyl acetate and sucralose from solution for use in chewing gum
IPC: A23L1/09
Filed: 1990-11-21
Granted: 1993-03-18
Abstract: A sucrose-containing chewing gum ingredient is prepared by mixing about 50 to about 95 parts by weight polyvinyl acetate with about 5 to about 50 parts by weight of a solution comprising sucralose dissolved in a solvent. The mixture is then dried to drive off the solvent. A chewing gum is prepared by mixing the sucralose-containing ingredient, gum base, a bulking agent and flavor to make a chewing gum composition.
Patent AU-629159-B2 (AU)
Title: Apparatus and method for a catheter adapter with valve
Inventor: PURDY EDMUND R
IPC: A61M39/26
Filed: 1991-05-29
Granted: 1992-09-24
Abstract: An over the needle catheter with adapter (10) that has an integral valve (11) in a passage (14). Distal (12) and proximal (13) parts form the adapter (10) along an axis "A". The distal part (12) communicates with a catheter (15). A hub (17) conjugates with the proximal part (13) and has a needle (18) extending along the axis "A" and through the passage (14) when the hub (17) is within the proximal part (13). A valve assembly (19) has an elongate resilient member (20) captured in the passage (14) between the parts (12,13). A proximal portion of the valve assembly (19) is engaged by a fitting (22) to open the valve. A valve seat (23) in the passage has a frusto-conical surface (24) located coaxial about the axis "A" and facing the distal part (12). The seat (23) engages a chamfered surface (25) on the elongate resilient member (20) to seal and prevent flow and to allow flow when the seal is broken by axial compression of the elongate resilient member (20) by the fitting (22). A septum like end (28) across the elongate resilient member (20) permits the needle (18) to pass therethrough in a resealable fashion. The elongate resilient member (20) has a diametrically reduced cylindrical body (32) extending to the septum like end (28). The passage (14) has an annular space (33) about the reduced cylindrical body (32) and terminates in a distal area (34). The distal area (34) has flow channels (37) which extend between the annular space (33) and the distal part (12). A method has steps of locating the parts along an axis "A" and capturing the elongate resilient member (20) by engaging the axially aligned parts (12,13) to force the elongate resilient member (20) against a valve seat (24) for sealing the passage (14) and preventing flow. Placing a needle (18) carried on a hub (17) along the axis "A" and through a septum like end (28) of the elongate resilient member (20) allows the needle (18) to be withdrawn from the septum like end (28) and to reseal the passage (14). Applying fastening means to secure the parts is a step.   <IMAGE>   <IMAGE>
Patent AU-651623-B2 (AU)
Title: Antibodies directed against CD3
Inventor: GORMAN SCOTT DAVID
IPC: C07K16/00
Filed: 1991-10-04
Granted: 1994-07-28
Abstract: Ligands with a binding affinity for the CD3 antigen having at least one CDR which is of different origin to the variable framework region and/or the constant region of the ligand, the at least one CDR being selected from the amino acid sequences: (a) Ser-Phe-Pro-Met-Ala, (b) Thr-Ile-Ser-Thr-Ser-Gly-Gly-Arg-Thr-Tyr-Tyr-Arg-Asp-Ser-Val-Lys-Gly, (c) Phe-Arg-Gln-Tyr-Ser-Gly-Gly-Phe-Asp-Tyr, (d) Thr-Leu-Ser-Ser-Gly-Asn-Ile-Glu-Asn-Asn-Tyr-Val-His, (e) Asp-Asp-Asp-Lys-Arg-Pro-Asp, (f) His-Ser-Tyr-Val-Ser-Ser-Phe-Asn-Val, and conservatively modified variants thereof, are of therapeutic value, particularly in the control of graft rejection.
Patent AU-748503-B2 (AU)
Title: Process for the preparation of 1-aryl-3-cyclopropyl-1,3-propanediones
Inventor: BERNARD DIDIER
IPC: C07C319/20
Filed: 1998-07-03
Granted: 2002-06-06
Abstract: A process for preparing a compound of the formula:which comprises reacting a compound of the formula:wherein R1 is C1-6 straight- or branched-chain alkyl, with a compound of the formula:in an aprotic solvent in the presence of base.
Patent AU-650309-B2 (AU)
Title: Abrasive on flexible backing and method of manufacture thereof
Inventor: EISENBERG GUSTAV
IPC: B24D3/28
Filed: 1991-12-30
Granted: 1994-06-16
Abstract: The object of the invention is to disclose an abrasive of the type in question, which, while avoiding the limitations which the abrasives of the prior art are subject to, calls for a lower proportion of abrasive grains and thus low costs but nonetheless ensures a performance comparable with conventional abrasives. This object is achieved in the abrasive according to the preamble of Claim 1 by these additives being present roughly in the size of the abrasive grain and having less hardness than the abrasive grain.
Patent AU-780234-B2 (AU)
Title: Device for lifting the anode frame of an electrolysis cell for the production of aluminium
Inventor: FRANTZ PHILIPPE
IPC: C25C3/10
Filed: 2001-11-14
Granted: 2005-03-10
Abstract: This device for lifting the anode frame of an electrolysis cell for the production of aluminium comprises: a horizontal cross-member (1) intended to be positioned above the cell in question; a plurality of members for gripping and holding (5) the anode rods (12) against the anode frame, comprising: a pressing module, pivoted (4) at its upper end to the said cross-member, so as to be able to undergo a pivoting movement with respect to the said cross-member, in such a way as to move away from the plane containing the anode rods on the same side of the cell and intended to keep the anode rods against the anode frame; and a gripping module, fastened to the pressing module and intended to ensure actual gripping of an anode rod.
Patent AU-747049-B2 (AU)
Title: Estrogen receptor
Inventor: WILKINSON HILARY
IPC: G01N33/566
Filed: 1998-09-04
Granted: 2002-05-09
Abstract: This invention relates to a novel estrogen receptor and to the polynucleotide sequences encoding this receptor. This invention also relates to methods for identifying ligands which bind to this receptor, to the ligands so identified, and to pharmaceutical compositions comprising such ligands. This invention also relates to pharmaceutical compositions useful for treating or preventing estrogen receptor mediated diseases or conditions, such as abnormal bone resorption, cardiovascular diseases, cancer, or central nervous system disorders.
Patent DE-2044446-B2 (DE)
Title: Stable rapidly assembled scaffolding support - has horizontal frames and vertical frames forming triangles with claw at tip engaging shell
IPC: E04G1/14
Filed: 1970-09-03
Abstract: A support section comprises a horizontal frame and a vertical frame and the vertical frames form triangular frameworks. These are connected together so that a claw is fitted at the apex of the triangle which engages into a shell on the vertical corner bar of the vertical frame. The slit width of the claw is smaller than the diameter of the shell and larger than the diameter of the corner bar of the vertical frame. The claw has a key lock, the key of which engages into a ring groove of the shell. To safeguard against the key being lost, a cotter in the outer locking component engages in a longitudinal slit in the key.